Bone turnover markers: understanding their value in clinical trials and clinical practice (Q37384765)

20 August 2017

1 reference

title

Bone turnover markers: understanding their value in clinical trials and clinical practice (English)

1 reference

20 August 2017

N Napoli

3

0 references

Roberto Civitelli

object named as

R Civitelli

series ordinal

1

0 references

author name string

R Armamento-Villareal

series ordinal

2

1 reference

PubMed ID

19190842

20 August 2017

language of work or name

English

0 references

publication date

4 February 2009

1 reference

Osteoporosis International

20 August 2017

1 reference

20 August 2017

20

1 reference

20 August 2017

843-851

1 reference

20 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-009-0838-9

20 August 2017

0 references

cites work

Collagen cross-linking compounds in human urine

1 reference

https://api.crossref.org/works/10.1007%2FS00198-009-0838-9

Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-009-0838-9

Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-009-0838-9

Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-009-0838-9

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

21 January 2018

1 reference

12 December 2020

Monitoring skeletal changes by radiological techniques.

1 reference

12 December 2020

Bone mineral density thresholds for pharmacological intervention to prevent fractures

1 reference

12 December 2020

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

1 reference

12 December 2020

No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial

1 reference

12 December 2020

Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures

1 reference

12 December 2020

Introduction--Bone turnover and fracture risk

1 reference

12 December 2020

Compliance with osteoporosis medications

1 reference

12 December 2020

Remodeling and skeletal fragility

1 reference

12 December 2020

The short-term effects of conjugated estrogen on bone turnover in older women

1 reference

12 December 2020

New automated multiplex assay for bone turnover markers in osteoporosis

1 reference

12 December 2020

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

1 reference

12 December 2020

The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates

1 reference

12 December 2020

Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region

1 reference

12 December 2020

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

FRAX and the assessment of fracture probability in men and women from the UK

1 reference

12 December 2020

Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study

1 reference

12 December 2020

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

12 December 2020

Diagnosis of osteoporosis and assessment of fracture risk

1 reference

12 December 2020

Clinical use of serum and urine bone markers in the management of osteoporosis

1 reference

12 December 2020

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis

1 reference

12 December 2020

New biomarkers of bone resorption

1 reference

12 December 2020

Urinary beta-1-galactosyl-0-hydroxylysine (GH) as a marker of collagen turnover of bone

1 reference

12 December 2020

Comparison of analytical performance and biological variability of three bone resorption assays

1 reference

12 December 2020

Comparing BMD results between two similar DXA systems using the generalized least significant change

1 reference

12 December 2020

Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks

1 reference

12 December 2020

Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro

1 reference

12 December 2020

The human alkaline phosphatases: what we know and what we don't know

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren.

1 reference

12 December 2020

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density

1 reference

12 December 2020

Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density

1 reference

12 December 2020

PINP as serum marker of metastatic spread to the bone in breast cancer patients.

1 reference

12 December 2020

Screening tests for intended medication adherence among the elderly.

1 reference

12 December 2020

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis.

1 reference

12 December 2020

Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls

1 reference

12 December 2020

Low-energy femoral shaft fractures associated with alendronate use.

1 reference

12 December 2020

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

12 December 2020

Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function

1 reference

12 December 2020

Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein

1 reference

12 December 2020

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

1 reference

12 December 2020

Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay

1 reference

12 December 2020

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

1 reference

12 December 2020

Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.

1 reference

12 December 2020

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women

1 reference

12 December 2020

Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study

1 reference

12 December 2020

Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

1 reference

12 December 2020

ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 50, January 2003

1 reference

12 December 2020

Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy.

1 reference

12 December 2020

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment

1 reference

12 December 2020

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links

1 reference

12 December 2020

Collagen in tendon, ligament, and bone healing. A current review.

1 reference

12 December 2020

Severely suppressed bone turnover and atypical skeletal fragility

1 reference

12 December 2020

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation

1 reference

12 December 2020

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial

1 reference

12 December 2020

Bone quality: where do we go from here?

1 reference

12 December 2020

Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.

1 reference

12 December 2020

Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practice

1 reference

12 December 2020

Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis

1 reference

12 December 2020

Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease

1 reference

12 December 2020

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

12 December 2020

Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.

1 reference

12 December 2020

Bisphosphonates: from the laboratory to the clinic and back again

1 reference

12 December 2020

Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis

1 reference

12 December 2020

Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis

1 reference

12 December 2020

Biochemical markers of bone turnover: part I: biochemistry and variability

1 reference

12 December 2020

Aging and matrix microdamage accumulation in human compact bone.

1 reference

12 December 2020

Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study

1 reference

12 December 2020

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

12 December 2020

Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis

1 reference

12 December 2020

Higher efficacy of urinary bone resorption marker measurements in assessing response to treatment for osteoporosis in postmenopausal women

1 reference

12 December 2020

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

1 reference

12 December 2020

Automated differential isoenzyme analysis. II. The fractionation of serum alkaline phosphatases into "liver", "intestinal" and "other" components

1 reference

12 December 2020

Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption

1 reference

12 December 2020

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

1 reference

12 December 2020

Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin

1 reference

12 December 2020

Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women

1 reference

12 December 2020

Monitoring alendronate therapy for osteoporosis

1 reference

12 December 2020

Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study).

1 reference

12 December 2020

Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover

1 reference

12 December 2020

10.1007/S00198-009-0838-9

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19190842